Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CLEW

Request full access

Predictive clinical analytics that ICU and high-acuity staff and management can use to avoid deteriorations

Netanya, IsraelFounded 2014Biotech & Life Sciences

About CLEW

CLEW is an analytics company operating in the HealthTech sector, providing an intelligent clinical surveillance platform for healthcare institutions. The firm was established in 2014 by co-founders Gal Salomon and Avigdor Faians in Netanya, Israel. Salomon’s motivation to create the company stemmed from a personal experience involving the loss of his mother due to what he perceived as an avoidable healthcare mistake, which drove him to develop a technological solution to prevent similar events. His background includes founding and leading Sansa Security until its acquisition by ARM, alongside roles at Pitango Venture Capital, Intel, and DSP Communications. Faians brings over two decades of experience in design management and system architecture from his time at companies like Mindspeed Technologies and Techtium.

The core of CLEW's business is a platform that uses artificial intelligence and machine learning models to anticipate patient deterioration, often hours before it would otherwise be detected. This system integrates clinical data from various sources, such as electronic health records (EHR) and bedside monitors, to create a consolidated, near real-time view of a patient's status. By providing predictive warnings, the technology enables care teams to intervene earlier, optimizing patient outcomes and resource allocation. The platform is designed for high-acuity settings within hospitals, including Intensive Care Units (ICUs), Emergency Departments (ED), and Post-Anesthesia Care Units (PACU). The business model centers on offering this AI-powered surveillance as a service to hospitals and healthcare systems, which helps them improve patient throughput and manage capacity more effectively. A significant milestone for the company was receiving FDA clearance in February 2021 for its AI-based predictive analytics technology for adult ICU patient assessment.

Source: Dealroom company data

At a glance

Status
Operational
Employees
17
Open positions
None listed
Dealroom signal
60.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Analytics, Predictive Analytics, Biotechnology, Staffing, Tech for Hospitals and Clinics, Clinical Decision Support
Technology
Artificial Intelligence, Big Data, Deep Tech, Machine Learning
Business model
SaaS
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Jan 2020 $10M $40M Pitango Venture Capital ↗
SERIES A✓Equity / VC Feb 2017 $8.4M $33M Rhoen Klinikum · Pitango Venture Capital ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

CLEW website traffic

Latest recorded traffic for CLEW is 160 monthly website visits, up 433.3% over the last three months. CLEW's team declined 39.3% over the past year.

Latest monthly visits160 3-month web change+433.3% 1-year team growth-39.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

CLEW in the Netanya ecosystem

Live from Dealroom

The CLEW office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Other known investors1 additional known investor

  • Agate Medical Investments
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See CLEW’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.